文献速递脑血管病神经重症与神经感染

脑室内纤维蛋白溶解与脑出血临床结局的关联:个体参与者数据荟萃分析

Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis.
PubMed 文献 · Stroke · 2022-05-06

该个体参与者数据荟萃分析汇总2项随机试验和7项观察性研究的1501例脑出血伴脑室内出血并接受脑室外引流患者,比较脑室内纤维蛋白溶解与标准治疗。结果显示脑室内纤维蛋白溶解与6个月功能结局改善显著相关,绝对治疗效应为9.3%(95%CI 4.4-14.1),且不增加不良事件。

要点

  • 脑室内纤维蛋白溶解与6个月功能结局改善显著相关,绝对治疗效应9.3%(95%CI 4.4-14.1)。
  • 脑室内纤维蛋白溶解组死亡率降低,OR 0.47(95%CI 0.35-0.64)。
  • 症状发作后≤48小时早期治疗与绝对治疗效应15.2%(95%CI 8.6-21.8)相关。

核心结论

  • 与标准治疗相比,脑室内纤维蛋白溶解与6个月功能结局改善显著相关。
  • 治疗效应与早期时间窗<48小时相关,为未来试验指定了目标人群。

研究设计与样本

  • 个体参与者数据荟萃分析,汇总2004至2015年入组的2项随机试验和7项观察性研究共1501例患者。
  • 比较脑室内纤维蛋白溶解与标准治疗(包括安慰剂),对象为因脑出血伴脑室内出血导致急性脑积水而接受脑室外引流的患者。

主要发现

  • 脑室内纤维蛋白溶解组596例 vs 标准治疗组905例,达到主要结局的绝对治疗效应为9.3%(95%CI 4.4-14.1)。
  • 脑室内纤维蛋白溶解组在mRS全范围估计中显示显著改善,共同OR 1.75(95%CI 1.39-2.17)。
  • 脑室内纤维蛋白溶解组死亡率降低,OR 0.47(95%CI 0.35-0.64)。
  • 不良事件绝对差异1.0%(95%CI -2.7至4.8),未增加不良事件。
  • 探索性分析显示症状发作后≤48小时早期脑室内纤维蛋白溶解与绝对治疗效应15.2%(95%CI 8.6-21.8)相关。

关键数值与推荐

  • 主要结局为6个月改良Rankin量表(mRS;范围0-6,较低分表示较少残疾),二分为mRS 0-3 vs mRS 4-6。
  • 次要结局包括序贯移位分析、全因死亡率和颅内不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with intracerebral hemorrhage (ICH), the presence of intraventricular hemorrhage constitutes a promising therapeutic target. Intraventricular fibrinolysis (IVF) reduces mortality, yet impact on functional disability remains unclear. Thus, we aimed to determine the influence of IVF on functional outcomes. METHODS: This individual participant data meta-analysis pooled 1501 patients from 2 randomized trials and 7 observational studies enrolled during 2004 to 2015. We compared IVF versus standard of care (including placebo) in patients treated with external ventricular drainage due to acute hydrocephalus caused by ICH with intraventricular hemorrhage. The primary outcome was functional disability evaluated by the modified Rankin Scale (mRS; range: 0-6, lower scores indicating less disability) at 6 months, dichotomized into mRS score: 0 to 3 versus mRS: 4 to 6. Secondary outcomes included ordinal-shift analysis, all-cause mortality, and intracranial adverse events. Confounding and bias were adjusted by random effects and doubly robust models to calculate odds ratios and absolute treatment effects (ATE). RESULTS: Comparing treatment of 596 with IVF to 905 with standard of care resulted in an ATE to achieve the primary outcome of 9.3% (95% CI, 4.4-14.1). IVF treatment showed a significant shift towards improved outcome across the entire range of mRS estimates, common odds ratio, 1.75 (95% CI, 1.39-2.17), reduced mortality, odds ratio, 0.47 (95% CI, 0.35-0.64), without increased adverse events, absolute difference, 1.0% (95% CI, -2.7 to 4.8). Exploratory analyses provided that early IVF treatment (≤48 hours) after symptom onset was associated with an ATE, 15.2% (95% CI, 8.6-21.8) to achieve the primary outcome. CONCLUSIONS: As compared to standard of care, the administration of IVF in patients with acute hydrocephalus caused by intracerebral and intraventricular hemorrhage was significantly associated with improved functional outcome at 6 months. The treatment effect was linked to an early time window <48 hours, specifying a target population for future trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kuramatsu JB, Gerner ST, Ziai W, et al. Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. Stroke. 2022. PMID: 35521958. doi:10.1161/STROKEAHA.121.038455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。